Skip to content
Medical Health Aged Care

World Falls Guidelines updates poised to dramatically reduce falls and ease $2.3b healthcare burden

Neuroscience Research Australia (NeuRA) 2 mins read

Key points


Falls are a growing issue globally, but two simple modifications to the World Falls Guidelines could dramatically improve prevention, new research from NeuRA (Neuroscience Research Australia) and UNSW has found.

In a new study published today in Age and Ageing today, researchers found that two simple changes to the World Falls Guidelines algorithm can significantly improve the classification of older adults into low, intermediate and high fall risk groups. This improvement is crucial, as research has shown that falls prevention programs — particularly exercise-based interventions — can reduce falls by up to 50 per cent. However, these programs are most effective when tailored to those with low, moderate and increased falls risk.

Professor Stephen Lord, Senior Principal Research Fellow and Director of the Falls, Balance and Injury Research Centre at NeuRA, said the previous World Guidelines for Falls Prevention and Management, launched in 2022, could not accurately identify people at moderate risk of falls.

“While the Falls Guidelines were developed to assist with identifying risk and supporting prevention, we found the algorithm missed significant groups. By refining the algorithm and incorporating a broader ‘Timed Up and Go’ test, we can now accurately identify those at intermediate risk and therefore posed to transition to high fall rates over the medium to long term,” Prof Lord said.

“This research has significant implications for fall risk assessment and prevention for health care providers working with older people.”

Improving falls risk assessment and prevention

These changes have significant implications for healthcare providers who work with older adults. The modified guidelines not only improve how falls risk is classified, but also enhances the effectiveness of falls prevention interventions.

The study compared the original and modified algorithms in 693 people aged 70-90. The modified algorithm successfully identified 18.3% of participants as intermediate-risk, compared to almost none with the original. This group shared characteristics with the high-risk group but had lower rates of falls, suggesting the modified algorithm could more accurately identify those who would benefit from targeted fall prevention, preventing their progression to ‘high risk’.

“The high-risk group had more than double the fall rate of the low-risk group and community living older people. For these individuals, we recommend multifactorial interventions such as addressing risk factors like hypotension, frailty, balance and mobility impairments, depressive symptoms and fear of falling,” Professor Lord said.

“This improvement in the algorithm is expected to lead to better triaging of older adults, ensuring they receive the personalised fall prevention interventions needed to reduce their risk.”

A crucial step forward

“The ageing of the Australian population means that the problem of fall-related injuries and deaths will worsen if we fail to take preventive action,” Prof Lord said.

“These modifications to the World Falls Guidelines represent a significant step towards reducing the burden of falls, enhancing quality of life and potentially saving lives.”

The full report is available at https://academic.oup.com/ageing/article/doi/10.1093/ageing/afae192/7796661

 


About us:

About NeuRA

Neuroscience Research Australia (NeuRA) is an independent, not-for-profit research institute based in Sydney aiming to prevent, treat and cure brain and nervous system diseases, disorders and injuries through medical research.

To learn more about NeuRA: www.neura.edu.au

Media

More from this category

  • Medical Health Aged Care
  • 01/10/2024
  • 23:11
SEPHORA

SEPHORA and Rare Beauty by Selena Gomez Commit to Second Year of Make A Rare Impact Campaign in Honor of World Mental Health Day

SEPHORA renews commitment to donating 100%* of global Rare Beauty product sales to the Rare Impact Fund on October 10 PARIS–BUSINESS WIRE– Today, SEPHORA…

  • Contains:
  • Medical Health Aged Care
  • 01/10/2024
  • 22:10
EnGeneIC

Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics

SYDNEY and NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has today announced the appointment of Dr. Daniel Von Hoff to its Scientific/Clinical Advisory Board to advise EnGeneIC’s on its upcoming trial in metastatic pancreatic cancer.Professor Daniel Von Hoff, M.D. F.A.C.P. FASCO, FAACR is an internationally recognized physician and scientist. He is currently Distinguished Professor at the Translational Genomics Research Institute (TGEN) in Phoenix, Arizona, and City of Hope and holds the Virginia G Piper Distinguished Chair for Innovative Cancer Research at Honor Health…

  • Medical Health Aged Care
  • 01/10/2024
  • 21:55
Curium

Curium Announces Strategic Partnership with PeptiDream for Prostate Cancer Theranostics in Japan

Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&TBuilds on long-standing relationship between the two companiesIn Japan around 90,000 new cases of prostate cancer are diagnosed each yearPARIS, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has entered into a strategic partnership with PDRadiopharma Inc, a wholly-owned subsidiary of PeptiDream, for the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T. The two agents 177Lu-PSMA-I&T and 64Cu-PSMA-I&T target prostate specific membrane antigen (PSMA) expressed on prostate cancer cells and are being…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.